These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 29219791)

  • 1. Effects of the Vitamin D Analog 2AMD in Cyclosporine-Induced Nephrotoxicity: Dose-Response and Antifibrotic Activity.
    Tomasini-Johansson B; O'Brien C; Larson-Osborne A; Toraason I; Hullett D; Plum L; DeLuca H; Sollinger H
    Exp Clin Transplant; 2017 Dec; 15(6):641-647. PubMed ID: 29219791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D receptor agonist VS-105 improves cardiac function in the presence of enalapril in 5/6 nephrectomized rats.
    Wu-Wong JR; Chen YW; Wessale JL
    Am J Physiol Renal Physiol; 2015 Feb; 308(4):F309-19. PubMed ID: 25503724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of a bone- and parathyroid-specific analog of vitamin D: 2-methylene-19-Nor-(20S)-1α,25-dihydroxyvitamin D3.
    Deluca HF
    Bonekey Rep; 2014; 3():514. PubMed ID: 24818006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New 19-nor-(20S)-1alpha,25-dihydroxyvitamin D3 analogs strongly stimulate osteoclast formation both in vivo and in vitro.
    Sato M; Nakamichi Y; Nakamura M; Sato N; Ninomiya T; Muto A; Nakamura H; Ozawa H; Iwasaki Y; Kobayashi E; Shimizu M; DeLuca HF; Takahashi N; Udagawa N
    Bone; 2007 Feb; 40(2):293-304. PubMed ID: 17070129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of a New Oral Vitamin D Receptor Activator (2-Methylene-19-Nor-(20S)-1α,25-Dihydroxyvitamin D
    Pandey R; Zella JB; Zhu JG; Plum LA; Clagett-Dame M; Blaser WJ; Bedale W; DeLuca HF; Coyne DW
    Drugs R D; 2017 Dec; 17(4):597-605. PubMed ID: 28905271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new vitamin D analog, 2MD, restores trabecular and cortical bone mass and strength in ovariectomized rats with established osteopenia.
    Ke HZ; Qi H; Crawford DT; Simmons HA; Xu G; Li M; Plum L; Clagett-Dame M; DeLuca HF; Thompson DD; Brown TA
    J Bone Miner Res; 2005 Oct; 20(10):1742-55. PubMed ID: 16160732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curative effect of sesame oil in a rat model of chronic kidney disease.
    Liu CT; Chien SP; Hsu DZ; Periasamy S; Liu MY
    Nephrology (Carlton); 2015 Dec; 20(12):922-30. PubMed ID: 26016645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel, selective vitamin D analog suppresses parathyroid hormone in uremic animals and postmenopausal women.
    Zella JB; Plum LA; Plowchalk DR; Potochoiba M; Clagett-Dame M; DeLuca HF
    Am J Nephrol; 2014; 39(6):476-83. PubMed ID: 24854296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ameliorative effect of ursolic acid on renal fibrosis in adenine-induced chronic kidney disease in rats.
    Thakur R; Sharma A; Lingaraju MC; Begum J; Kumar D; Mathesh K; Kumar P; Singh TU; Kumar D
    Biomed Pharmacother; 2018 May; 101():972-980. PubMed ID: 29635907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removal of the 20-methyl group from 2-methylene-19-nor-(20S)-1alpha,25-dihydroxyvitamin D(3) (2MD) selectively eliminates bone calcium mobilization activity.
    Barycki R; Sicinski RR; Plum LA; Grzywacz P; Clagett-Dame M; Deluca HF
    Bioorg Med Chem; 2009 Nov; 17(22):7658-69. PubMed ID: 19819702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yishen Jiangzhuo Granules affect tubulointerstitial fibrosis via a mitochondrion-mediated apoptotic pathway.
    Xu YF; Ruan SW; Lin JM; Zhang Z
    Chin J Integr Med; 2015 Dec; 21(12):928-37. PubMed ID: 25956968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymerized type I collagen reduces chronic cyclosporine nephrotoxicity.
    Sánchez-Pozos K; Lee-Montiel F; Pérez-Villalva R; Uribe N; Gamba G; Bazan-Perkins B; Bobadilla NA
    Nephrol Dial Transplant; 2010 Jul; 25(7):2150-8. PubMed ID: 20139407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity.
    Shihab FS; Yi H; Bennett WM; Andoh TF
    Kidney Int; 2000 Sep; 58(3):1174-85. PubMed ID: 10972680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified-release oral calcifediol corrects vitamin D insufficiency with minimal CYP24A1 upregulation.
    Petkovich M; Melnick J; White J; Tabash S; Strugnell S; Bishop CW
    J Steroid Biochem Mol Biol; 2015 Apr; 148():283-9. PubMed ID: 25446887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of calcitriol on peripheral endothelial progenitor cells and renal renovation in rats with chronic renal failure.
    Yang X; Wan JX; Yuan J; Dong R; Da JJ; Sun ZL; Zha Y
    J Steroid Biochem Mol Biol; 2021 Nov; 214():105956. PubMed ID: 34348182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of vitamin E and/or quercetin in attenuating chronic cyclosporine A-induced nephrotoxicity in male rats.
    Zal F; Mostafavi-Pour Z; Vessal M
    Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):720-4. PubMed ID: 17600547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine and rapamycin act in a synergistic and dose-dependent manner in a model of immunosuppressant-induced kidney damage.
    Brook NR; Waller JR; Bicknell GR; Nicholson ML
    Transplant Proc; 2005 Mar; 37(2):837-8. PubMed ID: 15848549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colchicine vs. omega-3 fatty acids for prevention of chronic cyclosporine nephrotoxicity in Sprague Dawley rats: an experimental animal model.
    Sabry A; El-Husseini A; Sheashaa H; Abdel-Shafy E; El-Dahshan K; Abdel-Rahim M; Abdel-Kaleek E; Abo-Zena H
    Arch Med Res; 2006 Nov; 37(8):933-40. PubMed ID: 17045107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-β/Smad and NF-κB signaling pathway in 5/6 nephrectomized rats.
    Wang DT; Huang RH; Cheng X; Zhang ZH; Yang YJ; Lin X
    Int Immunopharmacol; 2015 May; 26(1):4-12. PubMed ID: 25744602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.